About Lextrobio
Lextrobio is a Healthcare company based in India. It offers drug discovery, recombinant proteins, and antibody services in biotech. It operates on a B2B model. Its Indian entity Lextro Bio Solutions Private Limited reported revenue of ₹2.32 Cr. Lextrobio offers products and services including Concept to Clinics, Recombinant Proteins, Antibody Discovery, In-Vitro Services, and Pre-Clinical Services. Its focus areas include Life Sciences, Biotech, Protein Expression and Recombinant Proteins.
Company details
Lextro Bio Solutions is a biotech company based in Hyderabad, India, specializing in drug discovery and development technologies. They provide integrated services from concept to clinics, including recombinant proteins, antibody discovery, and pre-clinical studies for therapeutic areas like immune-oncology and infectious diseases. Their state-of-the-art infrastructure supports customers globally through partnerships and research collaborations.
- Headquarters India
- Employees 9
- SectorsHealthcare
- Email••••••••
- Website lextrobio.com
- Social LinkedIn
- Legal Name Lextro Bio Solutions Private Limited
- Date of Incorporation 23 Jun, 2022
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹2.32 Cr
FY 2025 · -12% YoY
- Net Loss-₹65.9 Lakh
FY 2025 · -28% margin
- EBITDA-₹45.6 Lakh
FY 2025 · -20% margin
- Employee Count9
Associated legal entities of Lextrobio
Lextrobio operates through Lextro Bio Solutions Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lextro Bio Solutions Private Limited CIN U24299TG2022PTC164017 | Active | 23 Jun 2022 | Hyderabad, Telangana | ₹2.3 Cr | 9 | 4 | View details |
Products & Services of Lextrobio
Lextrobio offers a comprehensive portfolio of products and services, including Concept to Clinics, Recombinant Proteins, Antibody Discovery, In-Vitro Services, and Pre-Clinical Services.
Integrated services for drug discovery in therapeutic areas.
Expression and purification of proteins in bacterial systems.
Generation of therapeutic and diagnostic antibodies.
Screening and lead identification for biological entities.
Pharmacology and toxicology studies for diseases.
In-vitro and in-vivo studies for drug candidates.
Board of directors of Lextro Bio Solutions Private Limited (Lextrobio)
Lextro Bio Solutions Private Limited is the primary company behind Lextrobio. The board of Lextro Bio Solutions Private Limited currently have 4 directors; the longest-serving is Srinivasa Chowdary Akkina, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Srinivasa Chowdary Akkina DIN 02658262 | Director | 23 Jun 2022 | 4 yrs 4 mo | Lextro Bio Solutions Private Limited |
| Srinivas Suveerji Cherukuri DIN 07248538 | Director | 23 Jun 2022 | 4 yrs 4 mo | Lextro Bio Solutions Private Limited |
| Muni Koteswara Rao Akkina DIN 02576546 | Director | 23 Jun 2022 | 4 yrs 4 mo | Lextro Bio Solutions Private Limited |
| Venkata Krishnaji Cherukuri DIN 02576559 | Director | 23 Jun 2022 | 4 yrs 4 mo | Lextro Bio Solutions Private Limited |
Financials of Lextrobio
Figures of Lextro Bio Solutions Private Limited, the primary company behind Lextrobio, for FY 2025. Revenue was ₹2.32 Cr (-12% year on year). Net loss was -₹65.9 Lakh (-28% margin). EBITDA was -₹45.6 Lakh (-20% margin).
- ₹2.32 CrRevenue · FY 2025 · -12% YoY
- -₹65.9 LakhNet loss · -28% margin
- -₹45.6 LakhEBITDA · -20% margin
- ₹1 LakhPaid-up capital
- 9Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Lextro Bio Solutions Private Limited are on its company page.
Detailed financial statements for Lextrobio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lextrobio
Lextrobio is headquartered in India.
Lextrobio has 9 employees.
The primary company behind Lextrobio, Lextro Bio Solutions Private Limited, reported revenue of ₹2.32 Cr for FY 2025, down 12% year on year.
Lextro Bio Solutions is a biotech company based in Hyderabad, India, specializing in drug discovery and development technologies. They provide integrated services from concept to clinics, including recombinant proteins, antibody discovery, and pre-clinical studies for therapeutic areas like immune-oncology and infectious diseases. Their state-of-the-art infrastructure supports customers globally through partnerships and research collaborations.
Lextrobio offers Concept to Clinics, Recombinant Proteins, Antibody Discovery, In-Vitro Services, and 2 more products and services.
Lextrobio operates through Lextro Bio Solutions Private Limited.
The legal entities of Lextrobio currently have 4 directors, including Srinivasa Chowdary Akkina, Srinivas Suveerji Cherukuri, Muni Koteswara Rao Akkina and others.